Labcorp (LH) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Labcorp · Health Care · ref. ETF XLV · 50 calls · price $313.64
What the company does: Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments.
📈 Labcorp (LH) stock price
$313.64+12.1% over range
Oct 14, 25low $246.64 · high $339.34Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
75% recommend buying · 8 analysts
📊 JPI status : Labcorp has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 LH price target & analyst consensus — price $314
The price target · all analysts combined (8 targets)
Highest target · 1 firm of 8$380+21.2%
Median target · of 8 targets$338+7.8%
Lowest target · 1 firm of 8$309-1.5%
Current price$313.64
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
788%
$320 ↔ $380
Below
113%
$309
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (830 calls tested). It aims for $338 (+7.8 %), call made on August 1, 2026, maturing on August 1, 2027 (74 d ago).
The 6 reliable analysts
$349+11 %
The 2 other firms
$329+4.9 %
How to read it: the 6 reliable firms are not filtered by optimism — 5 aim above the price, 1 below, hence their $349 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 8 ratings (last 6 months)
Strong Buy00%
Buy675%
Hold225%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 LH price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on LH most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in LH? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Labcorp? The JPI assistant answers using our backtest data.
💰 Labcorp dividend: yield, history & growth › open the full page
1.01%annual yield
That's ~$2.88 per share per year.
📈 Labcorp fundamentals: valuation, margins & growth › open the full page
P/E 25.9Net margin 7.0 %Revenue growth +5.8 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 9 %
2023
Rev −18%Profit −67%
2024
Rev +7%Profit +78%
2025
Rev +7%Profit +17%
🔎 Detailed analyses
✅ Historical analyst reliability on LH
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| SunTrust Robinson Humphrey | 100% | +56.2% | 3 |
| JP Morgan ↗ | 100% | +33.3% | 5 |
| Citigroup ↗ | 100% | +19.4% | 5 |
| Cantor Fitzgerald ↗ | 100% | +9.2% | 3 |
| UBS ↗ | 90% | +22.2% | 10 |
| Baird ↗ | 86% | +13.9% | 14 |
| Keybanc ↗ | 83% | +23.0% | 6 |
| B of A Securities ↗ | 83% | +17.4% | 6 |
| Truist Securities ↗ | 82% | +7.3% | 11 |
| Wells Fargo ↗ | 71% | +19.8% | 7 |
See the other 10 firms
| Credit Suisse | 44% | -1.4% | 16 |
| Jefferies ↗ | 50% | -2.9% | 4 |
| Goldman Sachs ↗ | 50% | -2.9% | 2 |
| Argus Research ↗ | 50% | +6.1% | 4 |
| Mizuho ↗ | 54% | +5.4% | 13 |
| Evercore ISI Group ↗ | 67% | +2.1% | 6 |
| Canaccord Genuity ↗ | 67% | +3.6% | 6 |
| Barclays ↗ | 67% | +17.1% | 9 |
| Morgan Stanley ↗ | 70% | +9.6% | 23 |
| Deutsche Bank ↗ | 71% | +11.3% | 7 |
📊 What $1,000 invested in Labcorp would be worth › open the full page
In short — $1,000 invested in Labcorp 10 years ago would be worth $2,636 today, i.e. +10%/yr on average. Best year: 2021 (+54%), worst: 2022 (-25%). Price performance, excluding dividends.
If I'd invested $1,000 in Labcorp
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,221 | +22% |
| 3 years ago | $1,384 | +38% |
| 5 years ago | $1,601 | +60% |
Return by year (Labcorp)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +12% | $1,116 (+12%) |
| 2025 | +9% | $1,221 (+22%) |
| 2024 | +1% | $1,232 (+23%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Labcorp
Loading news…
📋 All analyst calls on LH
Filtered on — · ✕ show all
Truist Securities ↗
Sep 21, 26
▲ Buy · 🎯$365
Price at call : $320.99 — upside +14%
Today : $313.64 — upside +16%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Sep 21, 27
matures : Sep 21, 27
▲ Buy · 🎯$380
Price at call : $315.31 — upside +21%
Today : $313.64 — upside +21%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Sep 11, 27
matures : Sep 11, 27
■ Equal-Weight neutral · not a buy · 🎯$330
Price at call : $315.31 — gap to target +5%
Today : $313.64 — gap to target +5%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Sep 11, 27
matures : Sep 11, 27
Piper Sandler ↗
Aug 4, 26
■ Neutral neutral · not a buy · 🎯$309
Price at call : $313.96 — gap to target -2%
Today : $313.64 — gap to target -1%
🎯 on LH : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
▲ Overweight · 🎯$360
Price at call : $312.34 — upside +15%
Today : $313.64 — upside +15%
🎯 on LH : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Aug 3, 27
matures : Aug 3, 27
Morgan Stanley ↗
Jul 31, 26
▲ Overweight · 🎯$338
Price at call : $307.42 — upside +10%
Today : $313.64 — upside +8%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Truist Securities ↗
Jul 31, 26
▲ Buy · 🎯$350
Price at call : $309.2 — upside +13%
Today : $313.64 — upside +12%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
■ Equal-Weight neutral · not a buy · 🎯$320
Price at call : $309.2 — gap to target +3%
Today : $313.64 — gap to target +2%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
See the other 42 calls, newest to oldest
B of A Securities ↗
Jul 13, 26
▲ Buy · 🎯$320
Price at call : $275.68 — upside +16%
Today : $313.64 — upside +2%
🎯 on LH : 100% (1 call matured) · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
▲ Outperform · 🎯$338
Price at call : $275.68 — upside +23%
Today : $313.64 — upside +8%
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
Evercore ISI Group ↗
Apr 8, 26
▲ Outperform · 🎯$300
Price at call : $273.26 — upside +10%
Today : $313.64 — upside -4%
🎯 on LH : 100% (4 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
Piper Sandler ↗
Feb 24, 26
■ Neutral neutral · not a buy · 🎯$300
Price at call : $282.78 — gap to target +6%
Today : $313.64 — gap to target -4%
🎯 on LH : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
▲ Overweight · 🎯$330
Price at call : $282.48 — upside +17%
Today : $313.64 — upside +5%
🎯 on LH : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
▲ Outperform · 🎯$326
Price at call : $278.76 — upside +17%
Today : $313.64 — upside +4%
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
▲ Overweight · 🎯$319
Price at call : $274.01 — upside +16%
Today : $313.64 — upside +2%
🎯 on LH : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Overweight · 🎯$317
Price at call : $261.13 — upside +21%
Today : $313.64 — upside +1%
🎯 on LH : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
▲ Buy · 🎯$320
Price at call : $252.33 — upside +27%
Today : $313.64 — upside +2%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
▲ Buy · 🎯$325
Price at call : $290.93 — upside +12%
Today : $313.64 — upside +4%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Oct 17, 26
matures : Oct 17, 26
▲ Outperform · 🎯$320
Price at call : $285.94 — upside +12%
Today : $313.64 — upside +2%
🎯 on LH : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Oct 17, 26
matures : Oct 17, 26
Evercore ISI Group ↗
Oct 3, 25
▲ Outperform · 🎯$305
Price at call : $275.05 — upside +11%
Today : $313.64 — upside -3%
Expected +11% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (4 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+12.2%
stock +12% · XLV +16%
matured Oct 3, 26
■ Equal-Weight neutral · not a buy · 🎯$290
Price at call : $276.94 — gap to target +5%
Today : $313.64 — gap to target -8%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 2, 26
matures : Oct 2, 26
Truist Securities ↗
Jul 25, 25
▲ Buy · 🎯$310
Price at call : $261.88 — upside +18%
Today : $313.64 — upside -1%
Expected +18% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
+15.0%
stock +15% · XLV +21%
matured Jul 25, 26
▲ Buy · 🎯$305
Price at call : $261.88 — upside +16%
Today : $313.64 — upside -3%
Expected +16% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
+15.0%
stock +15% · XLV +21%
matured Jul 25, 26
Evercore ISI Group ↗
Jul 25, 25
▲ Outperform · 🎯$300
Price at call : $261.88 — upside +15%
Today : $313.64 — upside -4%
Expected +15% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (4 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+15.0%
stock +15% · XLV +21%
matured Jul 25, 26
Morgan Stanley ↗
Jul 25, 25
▲ Overweight · 🎯$306
Price at call : $264.96 — upside +15%
Today : $313.64 — upside -2%
Expected +15% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
+13.7%
stock +14% · XLV +20%
matured Jul 25, 26
▲ Outperform · 🎯$302
Price at call : $264.96 — upside +14%
Today : $313.64 — upside -4%
Expected +14% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+13.7%
stock +14% · XLV +20%
matured Jul 25, 26
▲ Buy · 🎯$282
Price at call : $243.04 — upside +16%
Today : $313.64 — upside -10%
Expected +16% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
+15.8%
stock +16% · XLV +21%
matured Jul 18, 26
Evercore ISI Group ↗
Jul 9, 25
▲ Outperform · 🎯$285
Price at call : $259.07 — upside +10%
Today : $313.64 — upside -9%
Expected +10% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (4 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+7.2%
stock +7% · XLV +20%
matured Jul 9, 26
■ Equal-Weight neutral · not a buy · 🎯$275
Price at call : $256.98 — gap to target +7%
Today : $313.64 — gap to target -12%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jun 25, 26
matures : Jun 25, 26
Morgan Stanley ↗
Jun 11, 25
▲ Overweight · 🎯$283
Price at call : $261.65 — upside +8%
Today : $313.64 — upside -10%
Expected +8% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
+1.7%
stock +2% · XLV +12%
matured Jun 11, 26
Truist Securities ↗
May 12, 25
▲ Buy · 🎯$290
Price at call : $250.01 — upside +16%
Today : $313.64 — upside -8%
Expected +16% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
+1.8%
stock +2% · XLV +11%
matured May 12, 26
Piper Sandler ↗
May 6, 25
■ Neutral neutral · not a buy · 🎯$280
Price at call : $245.9 — gap to target +14%
Today : $313.64 — gap to target -11%
🎯 on LH : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : May 6, 26
matures : May 6, 26
■ Equal-Weight neutral · not a buy · 🎯$250
Price at call : $241.28 — gap to target +4%
Today : $313.64 — gap to target -20%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : May 1, 26
matures : May 1, 26
▲ Outperform · 🎯$267
Price at call : $241.28 — upside +11%
Today : $313.64 — upside -15%
Expected +11% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+6.0%
stock +6% · XLV +6%
matured Apr 30, 26
Truist Securities ↗
Apr 11, 25
▲ Buy · 🎯$274
Price at call : $221.46 — upside +24%
Today : $313.64 — upside -13%
Expected +24% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 49.4% · +2.3% (263 calls)
+19.3%
stock +19% · XLV +8%
matured Apr 11, 26
■ Equal-Weight neutral · not a buy · 🎯$240
Price at call : $221.46 — gap to target +8%
Today : $313.64 — gap to target -23%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 10, 26
matures : Apr 10, 26
Redburn Atlantic
Apr 2, 25
▲ Buy · 🎯$276
Price at call : $236.37 — upside +17%
Today : $313.64 — upside -12%
Expected +17% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (1 call matured) · 📊 unranked overall
+15.8%
stock +16% · XLV +2%
matured Apr 2, 26
▲ Buy · 🎯$300
Price at call : $256.81 — upside +17%
Today : $313.64 — upside -4%
Expected +17% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (1 call matured) · 📊 on Health : 53.1% · +2.4% (516 calls)
+9.4%
stock +9% · XLV +6%
matured Mar 4, 26
Piper Sandler ↗
Feb 10, 25
■ Neutral neutral · not a buy · 🎯$260
Price at call : $245.14 — gap to target +6%
Today : $313.64 — gap to target -17%
🎯 on LH : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Feb 10, 26
matures : Feb 10, 26
■ Equal-Weight neutral · not a buy · 🎯$260
Price at call : $245.08 — gap to target +6%
Today : $313.64 — gap to target -17%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 7, 26
matures : Feb 7, 26
▲ Buy · 🎯$290
Price at call : $246.27 — upside +18%
Today : $313.64 — upside -8%
Expected +18% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 51.2% · +4.7% (383 calls)
+11.3%
stock +11% · XLV +7%
matured Feb 7, 26
■ Equal-Weight neutral · not a buy · 🎯$271
Price at call : $246.67 — gap to target +10%
Today : $313.64 — gap to target -14%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 3, 26
matures : Feb 3, 26
▲ Buy · 🎯$286
Price at call : $246.22 — upside +16%
Today : $313.64 — upside -9%
Expected +16% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
+9.6%
stock +10% · XLV +6%
matured Jan 28, 26
Evercore ISI Group ↗
Jan 7, 25
▲ Outperform · 🎯$265
Price at call : $234.31 — upside +13%
Today : $313.64 — upside -16%
Expected +13% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (4 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+8.7%
stock +9% · XLV +13%
matured Jan 7, 26
Morgan Stanley ↗
Dec 17, 24
▲ Overweight · 🎯$270
Price at call : $226.31 — upside +19%
Today : $313.64 — upside -14%
Expected +19% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
+11.4%
stock +11% · XLV +12%
matured Dec 17, 25
B of A Securities ↗
Dec 13, 24
▲ Buy · 🎯$271
Price at call : $229.62 — upside +18%
Today : $313.64 — upside -14%
Expected +18% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (1 call matured) · 📊 on Health : 48.1% · +2.0% (362 calls)
+14.7%
stock +15% · XLV +12%
matured Dec 13, 25
▲ Buy · 🎯$275
Price at call : $234.54 — upside +17%
Today : $313.64 — upside -12%
Expected +17% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 51.2% · +4.7% (383 calls)
+11.7%
stock +12% · XLV +6%
matured Dec 10, 25
▲ Buy
Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (1 call matured) · 📊 on Health : 55.2% · +1.7% (29 calls)
+11.3%
stock +11% · XLV -2%
matured Oct 30, 25
Piper Sandler ↗
Oct 28, 24
■ Neutral neutral · not a buy · 🎯$240
Price at call : $228.09 — gap to target +5%
Today : $313.64 — gap to target -23%
🎯 on LH : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Oct 28, 25
matures : Oct 28, 25
Frequently asked questions
Should I buy Labcorp stock?
This isn't buy advice. For Labcorp, the analyst consensus is "Buy", with an average price target of $338 (+8% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Labcorp). We show the numbers — you decide.
Is it too late to buy Labcorp? How high can it go?
The most bullish analyst target on Labcorp is $380 (+21% above today's price); the average is $338. That's the upside they see. Check how reliable those analysts have actually been on Labcorp on our site before trusting it.
Is Labcorp still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 20 analysts have a real record on Labcorp, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Labcorp? The case for and against
The arguments for and against, one by one, from the numbers: why invest in LH (and why hesitate).
What has Labcorp's past performance been?
Historical returns and a "how much if I had invested" calculator: LH performance & returns.
Does Labcorp pay a dividend?
Yield, consistency and growth history of the dividend: LH's dividend.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX